Optimization of post-operative treatment of solid tumors following international guidelines by supportive long-term therapy with host tree specific fermented mistletoe (Viscum album L.) extracts

被引：0

作者：

Friedel, W. E. ^{[1
]}

Matthes, H. ^{[2
]}

Hanisch, J. ^{[3
]}

Bock, P. R. ^{[3
]}

机构：

[1] Hosp Bad Bocklet, Bad Bocklet, Germany

[2] Hosp Havelhoehe, Berlin, Germany

[3] IFAG Basel AG, Basel, Switzerland

来源：

ONKOLOGIE | 2010年 / 33卷

关键词：

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：192 / 192

页数：1

共 9 条

[1] Post-operative Treatment of Primary Colorectal Cancer can be Optimized by Supportive Long-term Therapy with the Host Tree Specific Fermented Extract of Mistletoe (Viscum album L.) from Oak Tree (quercus)
Matthes, H.
Friedel, W. E.
Bock, P. R.
ONKOLOGIE, 2010, 33 : 69 - 69
[2] Long-term supportive treatment with fermented mistletoe (viscum album L.) extract in primary nonmetastatic colorectal cancer: Best time to start with for optimal effectiveness
Matthes, H.
Friedel, W. E.
Bock, P. R.
JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
[3] FERMENTED MISTLETOE (VISCUM ALBUM L.) EXTRACT AS LONG-TERM SUPPORTIVE CARE IN PANCREATIC CARCINOMA OF UICC STAGES I-IV
Matthes, H.
Friedel, W. E.
Bock, P. R.
ANNALS OF ONCOLOGY, 2008, 19 : 180 - 180
[4] Treatment with a fermented mistletoe (Viscum album L.) extract as part of long-term supportive care in patients with primary non-metastatic colorectal carcinoma
Bock, P. R.
Hanisch, J.
Friedel, W. E.
Matthes, H.
PHYTOMEDICINE, 2007, 14 : 45 - 45
[5] IMPROVED QUALITY OF LIFE AND SURVIVAL TIME BY SUPPORTIVE LONG-TERM TREATMENT WITH FERMENTED MISTLETOE (VISCUM ALBUM L.) EXTRACT FROM OAK TREE IN PATIENTS WITH PANCREATIC CANCER OF ANY STAGE
Stauder, G.
Friedel, W.
Bock, P.
ANNALS OF ONCOLOGY, 2009, 20 : 105 - 105
[6] Treatment results with fermented mistletoe (Viscum album L.) extract as part of long-term supportive care in patients with primary non-metastatic colorectal carcinoma
Friedel, W.
Matthes, H.
Bock, P. R.
EJC SUPPLEMENTS, 2008, 6 (09): : 139 - 139
[7] Prospective controlled cohort studies on long-term therapy of ovarian cancer patients with mistletoe (Viscum album L.) extracts Iscador
Grossarth-Maticek, Ronald
Ziegler, Renatus
ARZNEIMITTELFORSCHUNG-DRUG RESEARCH, 2007, 57 (10): : 665 - 678
[8] Safety and efficacy of the long-term adjuvant treatment of primary intermediate- to high-risk malignant melanoma (UICC/AJCC stage II and III) with a standardized fermented European mistletoe (Viscum album L.) extract -: Results from a multicenter, comparative, epidemiological cohort study in Germany and Switzerland
Augustin, M
Bock, PR
Hanisch, J
Karasmann, M
Schneider, B
ARZNEIMITTELFORSCHUNG-DRUG RESEARCH, 2005, 55 (01): : 38 - 49
[9] Retrolective, comparative, epidemiological cohort study with parallel groups design for evaluation of efficacy and safety of drugs with 'well-Established use' -: Experience with the long-term treatment using the European mistletoe extract (Viscum album L.) in addition to conventional oncological therapy in primary, non-metastatic breast carcinoma
Bock, PR
Friedel, WE
Hanisch, J
Karasmann, M
Schneider, B
FORSCHENDE KOMPLEMENTARMEDIZIN UND KLASSISCHE NATURHEILKUNDE, 2004, 11 : 23 - 29

← 1 →